DexCom, Inc.
DXCM
주식 순위
#758
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
주가
$85.98
마지막 동기화: 2026-10-16
시가총액
$32.45B
변동 (1일)
-1.97%
변동 (1년)
29.10%
국가
US
거래 DexCom, Inc. (DXCM)
카테고리
Healthcare
DexCom, Inc. (DXCM)의 영업이익률
October 2026 기준 영업이익률 TTM: 22.92%
DexCom, Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 22.92%입니다. 2023년 말 기준 영업이익률은 16.50%였습니다.
DexCom, Inc.의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 22.92% | 54.03% |
| 2024 | 14.88% | -9.82% |
| 2023 | 16.50% | 22.77% |
| 2022 | 13.44% | 23.76% |
| 2021 | 10.86% | -30.12% |
| 2020 | 15.54% | 61.20% |
| 2019 | 9.64% | -153.38% |
| 2018 | -18.06% | 205.07% |
| 2017 | -5.92% | -46.91% |
| 2016 | -11.15% | -21.48% |
| 2015 | -14.20% | 71.29% |
| 2014 | -8.29% | -54.10% |
| 2013 | -18.06% | -67.61% |
| 2012 | -55.76% | -5.17% |
| 2011 | -58.80% | -36.86% |
| 2010 | -93.13% | -39.67% |
| 2009 | -154.36% | -71.25% |
| 2008 | -536.97% | -46.77% |
| 2007 | -1,008.77% | -55.62% |
| 2006 | -2,273.03% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 17.03% | -99.26% |
US
|
|
| 17.86% | -99.22% |
IE
|
|
| 22.03% | -99.04% |
US
|
|
| 21.46% | -99.06% |
US
|
|
| 0.00% | - |
DE
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.